Trial Profile
Growth Hormone Trial for Children With 18q- and Abnormal Growth
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Chromosome disorders; Growth disorders
- Focus Therapeutic Use
- 05 Aug 2016 Status changed from active, no longer recruiting to completed.
- 24 Oct 2014 New trial record